Dear Customers,Liotinib is a prescription-targeted anticancer drug. Orders must be placed with a valid prescription. We will strictly comply with phar···【Read More】
Update: 2026-01-21Source: Haiou HealthViews: 95
Liotinib is a tyrosine kinase inhibitor (TKI) primarily indicated for the treatment of malignant tumors driven by specific gene mutations, such as non···【Read More】
Update: 2026-01-21Source: Haiou HealthViews: 94
Liertinib (trade name: Aoyixin) is a prescription drug primarily indicated for the treatment of non-small cell lung cancer (NSCLC) with specific gene ···【Read More】
Update: 2026-01-21Source: Haiou HealthViews: 98
Lietinib Tablets (trade name: Aoyixin) is a prescription-only medication and must be used under the guidance of a physician. Below is relevant informa···【Read More】
Update: 2026-01-21Source: Haiou HealthViews: 121
The price of Liertinib (the exact name is subject to verification, as there may be a misstatement) has not been uniformly set and publicly announced. ···【Read More】
Update: 2026-01-21Source: Haiou HealthViews: 121
The price of Lirutinib varies depending on regions, dosage specifications, medical insurance policies, and purchasing channels. According to public da···【Read More】
Update: 2026-01-21Source: Haiou HealthViews: 124
Liotinib is a tyrosine kinase inhibitor primarily indicated for the targeted therapy of certain malignancies. Common adverse reactions include cutaneo···【Read More】
Update: 2026-01-20Source: Haiou HealthViews: 94
Yes, home delivery is available! You are required to provide a valid prescription. Based on our compliant qualifications, we will arrange delivery thr···【Read More】
Update: 2026-01-20Source: Haiou HealthViews: 104
The duration of administration for one box of Olverembatinib (generic name) depends on a comprehensive assessment of the daily dosage, treatment phase···【Read More】
Update: 2026-01-20Source: Haiou HealthViews: 101
Yes, Olverembatinib is a targeted therapy drug classified as a tyrosine kinase inhibitor. It exerts specific action on designated molecular targets (e···【Read More】
Update: 2026-01-20Source: Haiou HealthViews: 107
Olverembatinib is a third-generation BCR-ABL tyrosine kinase inhibitor (TKI). It is primarily indicated for the treatment of specific types of leukemi···【Read More】
Update: 2026-01-20Source: Haiou HealthViews: 102
On May 6, 2022, Olverembatinib Tablets, a Class 1 novel drug independently developed by the Guangzhou Institutes of Biomedicine and Health (GIBH), Chi···【Read More】
Update: 2026-01-20Source: Haiou HealthViews: 99
On November 25, Olverembatinib Tablets (trade name: Nileck®), a Class 1 New Drug independently developed by the Guangzhou Institute of Biomedicine and···【Read More】
Update: 2026-01-20Source: Haiou HealthViews: 98
The price of olverembatinib is affected by factors including specifications, regions and medical insurance policies. Currently, the reference price ra···【Read More】
Update: 2026-01-20Source: Haiou HealthViews: 99
The procurement cost of Olverembatinib can be reduced through the following legitimate channels: Prioritize confirming your eligibility for medical in···【Read More】
Update: 2026-01-20Source: Haiou HealthViews: 92
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



